A logo of Sanofi is pictured during the company’s shareholders meeting in Paris, France. File photo/Reuters
French drugs and healthcare group Sanofi said on Tuesday it had signed a rights deal with Roche for the ‘Tamiflu’ product in the United States.
The deal will give Sanofi exclusive US over-the-counter (OTC) rights to Tamiflu, which is used for the prevention and treatment of flu.
“This is a strategic and important transaction for us as we strive to continually bring innovations to the market,” said Alan Main, executive vice president of Sanofi’s consumer healthcare division, in a statement.
The European Union (EU) signed a landmark free trade deal with Vietnam on Sunday, the first of its kind with a developing country in Asia, paving the way for tariff reductions on 99% of goods between the trading bloc and Southeast Asian country.
South Africa’s Biovac Institute will start local production of Sanofi’s Hexaxim vaccine next year and Pfizer’s anti-pneumonia Prevnar 13 vaccine in 2021, boosting supply of life-saving drugs in its main market, its CEO said.
President Donald Trump on Thursday for the first time linked a dispute over telecom giant Huawei, which he views as a threat to American security, with a deal to resolve the US-China trade war.
Confirmation of a new Brexit deal sent sterling to a five-month high on Thursday and hoisted European stocks to a year-and-a-half peak, before familiar doubts about British parliamentary support for the agreement hauled them back.
Emirates NBD Bank on Thursday announced that it proposes to raise Dhs6.45 billion via a rights share offering to strengthen its capital base and support the future growth of the business.
The Abu Dhabi National Oil Company (Adnoc), Adani Group, BASF SE and Borealis AG have signed a Memorandum of Understanding, MoU, to engage in a joint feasibility study to further evaluate a collaboration